C10H8O2, triclinic, P1̅ (no. 2), a = 4.3814(5) Å, b = 10.021(1) Å, c = 10.040(1) Å, α = 67.097(3)°, β = 87.762(3)°, γ = 80.576(4)°, V = 400.4 Å3, Z = 2, Rgt(F) = 0.040, wRref(F2) = 0.089, T = 200 K
In the title compound, C11H10O3, the prop-2-yn-1-yl group is inclined to the benzene ring by 69 (7)°...
C2H6O⋅C6H6N2O⋅C7H6O4, triclinic, P1̄ (no. 2), a = 7.4217(18) Å, b = 7.7021(18) Å, c = 15.362(4) Å, α...
R factor = 0.039; wR factor = 0.113; data-to-parameter ratio = 17.9. In the title compound, C13H10O3...
C8H8O3, monoclinic, P21/c (no. 14), a = 6.3037(3) Å, b = 33.102(2) Å, c = 7.0471(4) Å, β = 102.105(3...
C14H10O2, triclinic, P1 (no. 2), a = 7.498(3) Å, b = 7.973(3) Å, c = 9.660(4) Å, α = 67.211(13)°, β ...
C13H8N2O6, triclinic, P1‾$P\bar{1}$ (no. 2), a = 6.9561(5) Å, b = 7.3040(5) Å, c = 13.2883(8) Å, α =...
C29H22O4, triclinic, Pī (No. 2), a= 10.795(3) Å, b= 12.877(5) Å, c = 7.877(2) Å, α = 97.20(3)°, β = ...
C22H21NO3, triclinic, P1̄ (no. 2), a = 5.757(3) Å, b = 12.106(5) Å, c = 13.139(6) Å, α = 93.725(12)°...
C15H12O3, monoclinic, C12/cl (No. 15), a = 23.63(4) Â, b = 5.58(1) Â, c = 17.98(3) Â, β = 95.1(1)°,...
C 15 H 14 O 4 , triclinic, P1 (no. 2), a = 5.3317(3) à , b = 11.0927(7) à , c = 11.3125(7) à , α = ...
C13H10O4, monoclinic, P21/n (no. 14), a = 9.3751(2) Å, b = 17.3340(3) Å, c = 13.3828(2) Å, β = 98.46...
In the title compound, C13H10O3, two prop-2-ynyloxy groups are attached to the benzaldehyde ring at ...
C19H20O4, monoclinic, P21/c (no. 14), a = 16.5979(5) Å, b = 8.5654(2) Å, c = 11.8418(4) Å, β = 10...
C17H22N2O3, monoclinic, P21/c, (no. 14) a = 18.419(4) Å, b = 5.7524(12) Å, c = 17.575(4) Å, β = 117....
The title compounds 5,5′-(propane-2,2-diyl)bis(2-hydroxybenzaldehyde), C17H16O4, (1), and 5,5′-(prop...
In the title compound, C11H10O3, the prop-2-yn-1-yl group is inclined to the benzene ring by 69 (7)°...
C2H6O⋅C6H6N2O⋅C7H6O4, triclinic, P1̄ (no. 2), a = 7.4217(18) Å, b = 7.7021(18) Å, c = 15.362(4) Å, α...
R factor = 0.039; wR factor = 0.113; data-to-parameter ratio = 17.9. In the title compound, C13H10O3...
C8H8O3, monoclinic, P21/c (no. 14), a = 6.3037(3) Å, b = 33.102(2) Å, c = 7.0471(4) Å, β = 102.105(3...
C14H10O2, triclinic, P1 (no. 2), a = 7.498(3) Å, b = 7.973(3) Å, c = 9.660(4) Å, α = 67.211(13)°, β ...
C13H8N2O6, triclinic, P1‾$P\bar{1}$ (no. 2), a = 6.9561(5) Å, b = 7.3040(5) Å, c = 13.2883(8) Å, α =...
C29H22O4, triclinic, Pī (No. 2), a= 10.795(3) Å, b= 12.877(5) Å, c = 7.877(2) Å, α = 97.20(3)°, β = ...
C22H21NO3, triclinic, P1̄ (no. 2), a = 5.757(3) Å, b = 12.106(5) Å, c = 13.139(6) Å, α = 93.725(12)°...
C15H12O3, monoclinic, C12/cl (No. 15), a = 23.63(4) Â, b = 5.58(1) Â, c = 17.98(3) Â, β = 95.1(1)°,...
C 15 H 14 O 4 , triclinic, P1 (no. 2), a = 5.3317(3) à , b = 11.0927(7) à , c = 11.3125(7) à , α = ...
C13H10O4, monoclinic, P21/n (no. 14), a = 9.3751(2) Å, b = 17.3340(3) Å, c = 13.3828(2) Å, β = 98.46...
In the title compound, C13H10O3, two prop-2-ynyloxy groups are attached to the benzaldehyde ring at ...
C19H20O4, monoclinic, P21/c (no. 14), a = 16.5979(5) Å, b = 8.5654(2) Å, c = 11.8418(4) Å, β = 10...
C17H22N2O3, monoclinic, P21/c, (no. 14) a = 18.419(4) Å, b = 5.7524(12) Å, c = 17.575(4) Å, β = 117....
The title compounds 5,5′-(propane-2,2-diyl)bis(2-hydroxybenzaldehyde), C17H16O4, (1), and 5,5′-(prop...
In the title compound, C11H10O3, the prop-2-yn-1-yl group is inclined to the benzene ring by 69 (7)°...
C2H6O⋅C6H6N2O⋅C7H6O4, triclinic, P1̄ (no. 2), a = 7.4217(18) Å, b = 7.7021(18) Å, c = 15.362(4) Å, α...
R factor = 0.039; wR factor = 0.113; data-to-parameter ratio = 17.9. In the title compound, C13H10O3...
DOI
Add to ORKG